Vivo Capital, LLC Igm Biosciences, Inc. Transaction History

Vivo Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$57.98 - $96.6 $1.16 Million - $1.93 Million	-20,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$47.41 - $115.03 $3.96 Million - $9.6 Million	-83,480 Reduced 80.67%	20,000 $1.77 Million
Q3 2020 Nov 13, 2020	SELL	$43.0 - $84.01 $688,000 - $1.34 Million	-16,000 Reduced 13.39%	103,480 $7.64 Million
Q2 2020 Aug 14, 2020	SELL	$51.3 - $75.21 $4.11 Million - $6.03 Million	-80,146 Reduced 40.15%	119,480 $8.72 Million
Q1 2020 May 15, 2020	BUY	$31.51 - $73.75 $6.29 Million - $14.7 Million	199,626 New	199,626 $11.2 Million

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.